Navigation Links
CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS

eutics. The Company owns three clinical-stage compounds based on its small molecule "molecular chaperone" co-induction technology. In September 2006, CytRx announced that arimoclomol was shown to be safe and well tolerated at all three doses tested in its Phase IIa clinical trial in patients with ALS. The Company plans to enter a Phase IIb clinical trial with arimoclomol in ALS in the second half of 2007, subject to FDA clearance. Based on preliminary discussions with the FDA, CytRx is now considering a second efficacy clinical trial for ALS, possibly in parallel with the upcoming Phase IIb trial, to provide additional efficacy data to support a possible approval decision by the FDA.

The FDA has granted Fast Track designation and Orphan Drug status to arimoclomol for the treatment of ALS, which has also been granted orphan medicinal product status for the treatment of ALS by the European Commission. The Company has announced plans to commence a Phase II clinical trial for arimoclomol in stroke recovery in the first half of 2008, subject to FDA clearance. The Company has also announced plans to commence a Phase II clinical trial with its next drug candidate, iroxanadine, for diabetic foot ulcers in the first half of 2008, subject to FDA clearance. In addition, the Company plans to open a research and development facility in San Diego in the third quarter of 2007. For more information on the Company, visit www.cytrx.com.

About RXi Pharmaceuticals Corporation

Worcester, Massachusetts-based RXi Pharmaceuticals Corporation, a majority-owned subsidiary of CytRx, is a biopharmaceutical research and development company that focuses on developing RNAi-based therapeutics for the treatment of human disease. RXi's initial focus is on neurodegenerative diseases, oncology, type 2 diabetes and obesity. RXi has licenses to a diverse series of early patents and patent applications that were filed from 1998 to 2006 in the areas of RNAi target sequences, RNAi chem
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
2. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
(Date:12/24/2014)... Wash. , Dec. 23, 2014  Advanced ... development company engaged primarily in the development of ... therapeutic applications, today announced that it has filed ... Food and Drug Administration ("FDA") for marketing clearance ... Section 513(f)(2) of the U.S. Food, Drug and ...
(Date:12/24/2014)... LifeScienceIndustryResearch.com adds 2014 ... Industry of 178 pages providing 10 company ... The 2014 Market Research Report ... professional and deep research report on Global ... report introduces Disposable Syringe basic information including ...
(Date:12/24/2014)... Dec. 23, 2014   Assurex Health, a ... to healthcare providers for behavioral health and chronic ... $30 million in equity financing from new and ... , President and Chief Executive Officer. ... development of Assurex Health,s GeneSight ® ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... June 1, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... today that Paul Bisaro, Watson,s President and Chief Executive ... Company,s business at the 2011 Goldman Sachs 32nd Annual ... 11:00am Eastern Time at the Terranea Resort in Rancho ...
... 2011 Hologic, Inc. (Hologic or the ... manufacturer and supplier of premium diagnostics, medical imaging systems ... of women, today announced it has acquired TCT International ... China, including Hologic,s ThinPrep Pap Test, related instruments and ...
Cached Medicine Technology:Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 2Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 3Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 4Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 5
(Date:12/24/2014)... The 2014 Market Research Report ... in-depth research report on COC industry. For an ... including its definition, classification, application, industry chain structure, ... report also presents product specification, manufacturing process, and ... regions, technology and applications. Analysis also covers upstream ...
(Date:12/24/2014)... FL (PRWEB) December 24, 2014 There’s a ... days. With the Republican Party now in control of the ... again for the Affordable Care Act. A lawsuit has been ... delays of certain provisions in the ACA have resulted in ... Also, a Supreme Court hearing will take place to weigh ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 For nearly ... blessings, housewarmings, new babies, graces, and all of life's ... poet and author, Nancy Tupper Ling, in Toasts: ... by Viva Editions. , Organized by category and ... that won't appear anywhere else, this timely tome contains ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 “ Relax ... its monthly AppWatch, which features the latest and coolest ... Andrew Tropeano, a mobile technology expert and host of ... how this application soothes users so they can fall ... 30% of adults say they have some sort of ...
(Date:12/24/2014)... Las Vegas, NV (PRWEB) December 24, 2014 ... Home Services reminds homeowners that before investing time ... start by consulting a licensed professional that specializes in ... who may plan to replace their water heater in ... making a final decision. , Greenstar Home Services ...
Breaking Medicine News(10 mins):Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 3Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2
... Engineers have developed a new type of microchip muscle stimulator ... paralysed leg muscles. It is the first time ... is small enough to be implanted into the spinal canal ... The implant is the size of a child,s fingernail. ...
... have become aware of the dangers of excessive fructose in ... of the Journal of the American Society of Nephrology ... sugar may be. Richard J. Johnson, MD and ... of Colorado) provide a concise overview of recent clinical and ...
... Nov. 22 (HealthDay News) -- Women who were sexually or ... problems, researchers say. In the study, researchers analyzed data ... U.S. National Alcohol Survey. The investigators found that women who ... more likely to also report that they drank four or ...
... , MONDAY, Nov. 22 (HealthDay News) -- The approximately ... each year in the United States cost the health care ... Control and Prevention said in its annual STD report released ... burden of STDs but there are some signs of progress, ...
... EDITOR,S PICK: Who is in your poo? ... Pamer, Carles Ubdea, and colleagues, at Memorial Sloan-Kettering ... suggest that high-throughput DNA sequencing of bacteria in ... life-threatening bloodstream infection with the antibiotic-resistant bacterium vancomycin-resistant ...
... Alexandria, Va. The American Association for Dental Research (AADR) ... the Washington, DC, area. This year, the theme was the ... & Clinical Frontiers. The symposium was sold-out, but AADR also ... AADR created the Fall Focused Symposium under the objective ...
Cached Medicine News:Health News:New spinal implant will help people with paraplegia to exercise paralyzed limbs 2Health News:Girls Who Suffer Child Abuse May Abuse Alcohol as Adults 2Health News:New STD Report Finds Some Progress, High Costs for U.S. 2Health News:JCI table of contents: Nov. 22, 2010 2Health News:JCI table of contents: Nov. 22, 2010 3Health News:JCI table of contents: Nov. 22, 2010 4Health News:JCI table of contents: Nov. 22, 2010 5Health News:JCI table of contents: Nov. 22, 2010 6Health News:JCI table of contents: Nov. 22, 2010 7Health News:JCI table of contents: Nov. 22, 2010 8Health News:JCI table of contents: Nov. 22, 2010 9Health News:JCI table of contents: Nov. 22, 2010 10Health News:JCI table of contents: Nov. 22, 2010 11Health News:JCI table of contents: Nov. 22, 2010 12Health News:Cutting-edge salivary diagnostics research presented at AADR 3rd Fall Focused Symposium 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: